Lisata Therapeutics, Inc.LSTANASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank14
3Y CAGR-43.2%
5Y CAGR-3.0%
Year-over-Year Change
Research and development spending
3Y CAGR
-43.2%/yr
vs +54.7%/yr prior
5Y CAGR
-3.0%/yr
Recent deceleration
Acceleration
-97.9pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $7.95M | -29.9% |
| 2024 | $11.33M | -11.0% |
| 2023 | $12.73M | -70.7% |
| 2022 | $43.46M | +147.3% |
| 2021 | $17.58M | +89.9% |
| 2020 | $9.25M | -31.4% |
| 2019 | $13.50M | +77.7% |
| 2018 | $7.59M | -55.7% |
| 2017 | $17.14M | +13.5% |
| 2016 | $15.11M | - |